Anatara Lifesciences Ltd (AU:ANR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Anatara Lifesciences Ltd is hosting a webinar to discuss its progress on the Stage 2 clinical trial for IBS and a new anti-obesity program, alongside details of a Share Purchase Plan. Investors and interested parties are invited to join the session to gain insights into the company’s innovative pipeline of health products. This presents a valuable opportunity for stakeholders to understand Anatara’s strategic focus on gastrointestinal health and weight management solutions.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.